These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9563984)

  • 21. Sumatriptan. An updated review of its use in migraine.
    Perry CM; Markham A
    Drugs; 1998 Jun; 55(6):889-922. PubMed ID: 9617601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Sumatriptan nasal spray 20mg: efficacy, tolerance and quality of life in migraine patients].
    Géraud G; Valette C
    Rev Neurol (Paris); 2000 Jul; 156(6-7):646-53. PubMed ID: 10891800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies to assess if pizotifen prophylaxis improves migraine beyond the benefit offered by acute sumatriptan therapy alone.
    Cleland PG; Barnes D; Elrington GM; Loizou LA; Rawes GD
    Eur Neurol; 1997; 38(1):31-8. PubMed ID: 9252796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Building on the sumatriptan experience: the development of naratriptan.
    Connor HE
    Cephalalgia; 2001; 21 Suppl 1():32-4. PubMed ID: 11678820
    [No Abstract]   [Full Text] [Related]  

  • 25. The 5-HT1-like agonist sumatriptan has a significant effect in chronic tension-type headache.
    Brennum J; Kjeldsen M; Olesen J
    Cephalalgia; 1992 Dec; 12(6):375-9. PubMed ID: 1335361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transient minor improvement of high altitude headache by sumatriptan.
    Utiger D; Eichenberger U; Bernasch D; Baumgartner RW; Bärtsch P
    High Alt Med Biol; 2002; 3(4):387-93. PubMed ID: 12631424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A 27-year-old woman with migraine headaches.
    Welch KM
    JAMA; 1997 Jul 23-30; 278(4):322-8. PubMed ID: 9228439
    [No Abstract]   [Full Text] [Related]  

  • 28. Topical agents in the treatment of cluster headache.
    Markley HG
    Curr Pain Headache Rep; 2003 Apr; 7(2):139-43. PubMed ID: 12628056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Migraine polypharmacy and the tolerability of sumatriptan: a large-scale, prospective study.
    Putnam GP; O'Quinn S; Bolden-Watson CP; Davis RL; Gutterman DL; Fox AW
    Cephalalgia; 1999 Sep; 19(7):668-75. PubMed ID: 10524661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective large-scale study of the tolerability of subcutaneous sumatriptan injection for acute treatment of migraine.
    O'Quinn S; Davis RL; Gutterman DL; Pait GD; Fox AW
    Cephalalgia; 1999 May; 19(4):223-31; discussion 200. PubMed ID: 10376167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SUMATRIPTAN: a receptor-targeted treatment for migraine.
    Moskowitz MA; Cutrer FM
    Annu Rev Med; 1993; 44():145-54. PubMed ID: 8386498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sumatriptan: efficacy and contribution to migraine mechanisms.
    Pearce JM
    J Neurol Neurosurg Psychiatry; 1992 Dec; 55(12):1103-5. PubMed ID: 1336041
    [No Abstract]   [Full Text] [Related]  

  • 33. Efficacy and adverse events of subcutaneous, oral, and intranasal sumatriptan used for migraine treatment: a systematic review based on number needed to treat.
    Tfelt-Hansen P
    Cephalalgia; 1998 Oct; 18(8):532-8. PubMed ID: 9827244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sumatriptan for the treatment of migraine attacks--a review of controlled clinical trials.
    Tfelt-Hansen P
    Cephalalgia; 1993 Aug; 13(4):238-44. PubMed ID: 8397070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The problems of migraine headache treatment].
    Vilionskis A; Vaitkus A
    Medicina (Kaunas); 2002; 38(7):679-84. PubMed ID: 12474651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing patient preference in migraine treatment.
    Dahlöf C
    Cephalalgia; 2001 Oct; 21(8):791-5. PubMed ID: 11737002
    [No Abstract]   [Full Text] [Related]  

  • 37. Subcutaneous sumatriptan in the treatment of acute episodes of posttraumatic headache.
    Gawel MJ; Rothbart P; Jacobs H
    Headache; 1993 Feb; 33(2):96-7. PubMed ID: 8384612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of the anti-migraine drug sumatriptan on muscle energy metabolism: relationship to side-effects.
    Boska MD; Welch KM; Schultz L; Nelson J
    Cephalalgia; 2000 Feb; 20(1):39-44. PubMed ID: 10817445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolonged migraine aura without headache arrested by sumatriptan. A case report with further considerations.
    Kowacs PA; Piovesan EJ; Tatsui CE; Lange MC; Ribas LC; Werneck LC
    Cephalalgia; 1999 May; 19(4):241-2. PubMed ID: 10376169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SUNCT syndrome.
    Ghose RR
    Med J Aust; 1995 Jun; 162(12):667-8. PubMed ID: 7603383
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.